Internal radiation dose estimates in organs of Wistar rats exposed to sprayed neutron-activated 31SiO2 microparticles: first results of international multicenter study Authors: Valeriy Stepanenko, Hitoshi Sato, Andrey Kaprin, Nariaki Fujimoto, Almagul Kushugulova, Sergey Ivanov, Peter Shegay, Viktoria Bogacheva, Alexey Petukhov, Kassym Zhumadilov, Evgenia Ostroumova, Hiroshi Yasuda, Noriyuki Kawano, Megu Ohtaki, Satoru Endo, Aya Sakaguchi, Laura Chulenbayeva, Nurislam Mukhanbetzhanov, Masaharu Hoshi Published: 2024 ABSTRACT AbstractNeutron-activated 31Si is an almost pure beta emitter and is one of the short-lived radionuclides, including beta-gamma emitter 56Mn, which were created in a form of residual radioactivity in the early period after the atomic bombing of Hiroshima and Nagasaki. The features of the biological effects of internal irradiation by these radionuclides are a subject of scientific discussions and research. The publication presents data on internal radiation doses in experimental Wistar rats that were exposed to sprayed neutron-activated microparticles of 31SiO2. Doses of internal radiation could be conditionally divided into three groups according to their values. It has been found that elevated values of internal radiation doses in rats’ organs/tissues as a result of exposure to sprayed 31SiO2 microparticles with initial activity of 3.2 × 107 Bq varied from 10 to 120 mGy (eyes, lungs, skin, stomach, jejunum, large intestine). The moderate dose values were in the range from 1.9 to 3.7 mGy (trachea, esophagus, ileum). The smallest doses were received by the kidney, testis, blood, cerebellum, heart, liver, cerebrum, bladder, spleen and thymus (from 0.11 to 0.94 mGy). The obtained data are important for interpreting the results of ongoing and planned biological experiments with 31SiO2 microparticles—in comparison with the previously published data on features of biological effects caused by beta-gamma emitting 56MnO2 neutron-activated microparticles.Keywords: dosimetry, internal irradiation, Wistar rats, neutron activation, 31SiO2, radioactive microparticles, atomic bombing INTRODUCTION There are a number of short-lived neutron-activated radionuclides, which are significant part of residual radioactivity as dose-forming factors in the early stage after the atomic bombing of Hiroshima and Nagasaki on 6 and 9 August 1945 [1–4]. Silicon-31 (31Si) is one of these radionuclides. Scientific research and discussions on the impact of exposure in relation to biological effects from the residual radioactivity following the A-bombing are ongoing [5–7]. The reason for that is an earlier publication on harmful radiation effects observed in the persons who came to Hiroshima shortly after the nuclear detonation, but who were not exposed to the initial gamma-neutron radiation at the moment of explosion [8–12]. As a result, there is a reason to believe that exposure of these individuals to the residual radioactivity in the early stage after the atomic bombing was the main cause of the reported health effects. Meanwhile, in very early and even in more recent documents, little attention was given to the residual radiation after the atomic bombardments of Hiroshima and Nagasaki [13–16]. That is why, international studies on features of biological effects and assessments of internal radiation doses in experimental rats and mice exposed to neutron-activated radiation from sprayed microparticles with short-lived radionuclides were carried out now [7, 17–29] and ongoing. It should be pointed out that radiobiological studies on laboratory animals are not intended directly to exact model all conditions of radioactive particles fallout from the atomic-bomb explosions, which is impossible in experimental situation. On the other hand, short-lived neutron-activated radionuclides 31Si (T1/2 = 2.62 h) and 56Mn (T1/2 = 2.58 h) are belonging to the main dose-forming factors from neutron-activated residual radioactivity during the first hours after atmospheric atomic explosions [1, 2]. It was found in radiobiological experiments with internal irradiation to 56Mn02 microparticles, that rat’s lung tissue was severely damaged by exposure to 56Mn [17, 18], despite a rather low radiation dose (the averaged over volume of rats lungs absorbed dose of internal radiation is less than 0.1 Gy [19–23]). Significant biological impact of internal exposure to neutron-activated microparticles with 56Mn was found for other radiobiological effects in experiments with rats and mice of different strains [17, 24–28]. The radiation from 31Si consists of intensive short-range beta particles (100%). Gamma-radiation of 31Si has very low intensity (0,07%). This is principal difference from the radiation of 56Mn, which includes intensive beta particles (100%) and intensive gamma rays (143%). These differences can lead to differences in local absorbed dose around 31SiO2 and 56MnO2 microparticles entered to biological microstructures. As it was shown in [18, 29], local radiation dose in biological microstructures irradiated by 56MnO2 microparticles plays significant role in observed biological effects. Here, we report the data on internal radiation doses averaged over volumes of various organs and tissues of experimental rats exposed to sprayed neutron-activated 31SiO2 microparticles—with almost pure beta emitting 31Si. This is the first stage of internal dose estimates related to 31Si. As to the peculiarities of local dose distributions in biological microstructures irradiated by 31SiO2 particles, the corresponding investigations are ongoing. Results of internal dose estimates related to 31SiO2 particles exposure are important for comparative analysis of biological effects caused by internal irradiation from the radioactive microparticles, which have different types of radiation: almost pure beta particles radiation from 31Si vs mixed beta-gamma radiation from 56Mn [7, 30]. MATERIALS AND METHODS Irradiation and experimental animals High-purity (>99.9%) silicon dioxide microparticles (SiO2) (Admatechs, Japan) with an average diameter of 2.4 μm were used as a substance for neutron activation. Neutron irradiation of SiO2 microparticles was carried out at the Research Nuclear Reactor WWR-K of the Institute of Nuclear Physics (Almay, Kazakhstan [31]) by thermal neutrons flux of 7.26 × 1013 neutron/(cm2 × s) with duration of irradiation equal to 300 s. The activity of 31Si (T1/2 = 157.3 minutes) obtained as a result of neutron activation was equal to 4.92 × 107 Bq per 1 g of SiO2 microparticles. Animal experiment was performed in accordance with the Approval by Ethics Committee of Kazakh National Medical University named after S.D. Asfendiyarov (Protocol # 7 (1457), 7 September 2023, Almaty, Republic of Kazakhstan), and in accordance with the Directive 2010/63/EU of the European Parliament and the Council of 22 September 2010 on the protection of animals used for scientific purposes [32]. Neutron-activated 31SiO2 powder was sprayed over the experimental animals using a special exposure box with forced ventilation (Fig. 1) similar to the box that was used in experiments with neutron-activated 56MnO2 microparticles [17, 21–23]. The features of this box were the following: (i) the main part of the construction was an isolated box where experimental animals were placed, preventing a release of radioactive microparticles into the environment; (ii) the box was connected with a forced ventilation system and equipped with an air filter that were necessary to ensure the breathing of animals; (iii) the box was connected with a pneumatic system, which, with a stream of air, sprayed radioactive powder over animals in the box. The sizes of the exposure box were enough to place inside up to seven experimental rats having a length of 85 cm, width of 55 cm, and height of 60 cm. For the exposure to sprayed radioactive powder (31SiO2 microparticles), two identical boxes were used. Thirteen experimental rats were exposed simultaneously: seven rats were placed in the first box for subsequent biological studies and six rats were placed in the second box, for both biological and dosimetric studies. Outbreed Wistar male rats, 10 weeks old, and with mean body mass of 311 g ± 7.6 g (SD), were used for the experiment. These rats were bred in the animal research facility of the Kazakh National Medical University named after S.D. Asfendiyarov and their health status corresponded to the specific pathogen-free (‘SPF’) conditions [33]. Exposure to SiO2 microparticles began 95 minutes after the completion of neutron activation. In each box with the experimental rats, 1000 mg of 31SiO2 powder was sprayed. The activity of sprayed 31SiO2 microparticles at the start of exposure was equal to 3.2 × 107 Bq in each box. The duration of rats’ keeping in the box used for spraying of neutron-activated 31SiO2 was equal to 90 minutes. After 90 minutes, experimental animals were removed from the box. General view of the box used for spraying of neutron-activated 31SiO2 powder over the experimental animals. Ten minutes after the end of exposure, all rats were euthanized by whole blood removal from an abdominal artery under anesthesia induced by isoflurane [34]. After euthanasia, the rats were dissected to obtain organ/tissue samples. Each extracted sample was minced with a scalpel so that thin layers of biological samples (1.9 mm thickness) could be obtained for the subsequent radiometry of 31Si beta radiation. Surgical extraction and preparation of biological samples were performed during 16–123 minutes after rats’ removal from the boxes used for exposure. To avoid cross-contamination of tissue and organ samples, new tweezers, scissors and scalpels, which did not have radioactive contamination, were used for each procedure. Each crushed biological sample was placed in a thin-walled labeled plastic dish with a known weight. The gross weight of each plastic dish with the sample was measured on high-precision analytical balances, and then the net weight of the biological sample was recorded. After this, each weighted dish with a sample was promptly transferred for radiometry of 31Si beta radiation. Radiometry of biological samples was performed 115–325 minutes after the beginning of exposure. The time periods of all procedures indicated above were recorded to take into account the decay of short-lived 31Si. Radiometry was carried out in a separate room. Walls of the room for radiometry were shielded with lead sheets of 5 mm thickness and 1.5 m height. Methodology of dose estimates Estimates of absorbed doses of internal radiation were performed in accordance with the methodology of the Medical Internal Radiation Dose Committee (MIRD) [35] using the results of measurements of 31Si-specific activity in the rats’ organs and tissues, as well on the basis of calculated absorbed fractions (AF) of energy emitted by beta particles from 31Si accumulated in organs and tissues. At AF calculations, the 31Si beta emission energy spectrum was approximated by 20 electron energy lines using the Radiation Dose Assessment Resource (RADAR) data (Fig. 2). AFs were calculated using Monte Carlo (MC) program (MCNP-4C) [36], and an age-dependent mathematical phantom of an experimental rat was used as well [37, 38]. It was assumed that the chemical composition and density of rat’s organs and tissues are similar to those of the human body [39]. Comparison of 31Si and 32P beta emission spectra [40–42] approximated by 20 energy lines. The maximum and average energies of 31Si beta particles are of 1.492 and 0.595 MeV, respectively. The maximum and average energies of 32P beta particles are of 1.709 and 0.695 MeV, respectively. RESULTS 31Si beta particles counting with developed stand and calibration of counter Special stand equipped with high-sensitive ‘Ranger Exp’ Geiger-Mueller (GM) counter (S.E. International, Inc.) was developed to measure beta radiation from biological samples. Figure 3 shows a scheme describing all parts of the measurement stand used. Schematic view of the stand to measure beta radiation from a biological sample by GM counter. There are upper dish (1) and lower dish (2), respectively, which were located in the stand to measure 31Si beta radiation from a biological sample. A crushed biological sample (3) of 1.9 mm thickness was placed between the bottom of the upper dish and bottom of the lower dish. Dishes were made of polymethyl methacrylate (PMMA) of 0.74 mm thickness and 1.19 g/cm3 density. Polyethylene protective sheet (4) of 0.1 mm thickness and 0.93 g/cm3 density, was designed to protect the thin mica window (5) of GM probe (6). Mica window had 1.4–2.0 mg/cm2 areal density and 45 mm effective diameter. There were air gaps (7) with a thickness of 2.5 mm (upper) and 1.75 mm (lower), respectively. The holder (8) of the entire construction was made of PMMA. The Geiger-Mueller counter with an external Halogen-quenched, uncompensated GM probe, was calibrated as follows. At the first stage, 32P source was used for calibration. The choice of 32P was made because this radionuclide, like 31Si, is a pure beta emitter, and the shapes of beta particle energy spectra for both of these radionuclides are similar as shown in Fig. 2 (with some differences in the mean and maximum energies of beta particles) [41]. Radionuclide 32P is more convenient for calibration measurements, because its half-life (T1/2 = 14.26 days) significantly exceeds the half-life of the short-lived 31Si (T1/2 = 157.3 minutes). To prepare 32P source for GM counter calibration, a standard solution with 32P (PerkinElmer, Inc.) was used. Different standard activities of 32P (ranged from 30 to 330 Bq) in a form of solution were dropped, dried, and adhered on the surface of polymethyl methacrylate (PMMA) plates. The obtained standard 32P sources in a form of very thin layers with diameter of 5 mm adhered to the surface of this PMMA plate were placed in the same stand, which was used for measurements of 31Si activity in biological samples (Fig. 3). Measurements of counts from standard 32P sources were carried out by ‘Ranger Exp’ GM counter. The geometry of 32P standard sources measurements was similar to the geometry of radiometry of 31Si beta radiation from biological samples, but with only one exception: unlike biological samples with mean thickness of 1.9 ± 0.03 mm (SD), the 32P standard sources were in a form of layers with very small thickness, which were adhered to the surface of PMMA plate. It was assumed that the absorption of 32P beta particles in these very thin layers of the standard sources was negligible. At the second stage, the value of the calibration coefficient, obtained as a result of the measurements of beta particle counts from thin standard 32P sources, was recalculated for 1.9-mm thick biological samples with beta-emitting 31Si. This recalculation was performed using Monte-Carlo method [36]. When recalculating by MC method, we took into account the self-absorption of 31Si beta particles in a 1.9-mm thick with a diameter of 5 mm biological sample, backscattering of 31Si beta particles from a PMMA plate, as well as differences in beta particles energy spectrum of 32P and 31Si (Fig. 2). That is, in this recalculation, a biological sample of 1.9 mm thickness was considered as a source of 31Si beta particles. It was assumed that 31SiO2 microparticles are homogeneously distributed within the volume of biological sample. As a result of MC recalculation, the value of calibration coefficient for 1.9 mm ± 0.03 mm-thick biological sample considered as a 31Si radioactive source was estimated equal to 0.12 ± 0.007 (SD) counts/s per 1 Bq of 31Si. Results of dose estimations According to the MIRD’s methodology, internal radiation doses were calculated taking into account accumulated activity of 31Si in all considered organs and tissues of rats. The measured specific activity of 31Si in rats’ organs and tissues was recalculated from the time of activity measurement to the moment of the beginning of animals’ irradiation, taking into account the physical half-life of 31Si. The accumulated internal radiation doses were estimated for the time period from the start of exposure to infinity (until the complete decay of 31Si). It must be emphasized that radioactive microparticles of 31SiO2 were sprayed over experimental animals using a pulse of compressed air from a special pneumatic system (Fig. 1). The duration of this pulse was 20 seconds. Therefore, it was assumed that the inhalation intake of microparticles into the animals’ respiratory system was short-term (not more than 1 minute)—as long as the 31SiO2 microparticles were suspended in the air of the box. After spraying, radioactive powder was deposited on the walls and floor of the box, as well as retained by the hair of the animals’ skin. Radioactive microparticles deposited on walls and floors and retained on the hair were swallowed by experimental rats in the process of cleaning and grooming. The duration of high activity of rats on cleaning and grooming was observed for about 20 minutes after spraying the radioactive powder. The animals then calmed down and their behavior became less active, and the cleaning process ended. Therefore, it was assumed that the intake of radioactive particles by ingestion (swallowing) was also relatively short-term (about 20 minutes), in comparison with decay of 31Si (T1/2 = 157.3 minutes). As a result, dose calculations were performed assuming a single intake of the activity. This assumption is consistent with duration of intake by inhalation (estimated duration of inhalation is about 1 minute). Regarding duration of intake by swallowing, assumption about single intake is less consistent—as far as duration of swallowing was estimated equal to 20 minutes compared to the half-life of 31Si equal to 157.3 minutes. Therefore, the assumption of a single intake of radioactive particles through ingestion should be considered somewhat conservative. Nevertheless, the assumption about single intake by swallowing was considered acceptable, since the duration of ingestion of about 20 minutes is ~eight times less than the half-life of 31Si. It was suggested as well, similar to [21–23], that the physical decay of 31Si is essentially faster in comparison with further biological redistribution of 31SiO2 microparticles in the experimental rat’s organism. It was assumed, that 31SiO2 microparticles were homogeneously distributed in organs and tissues. It means that the accumulated doses of internal radiation were the average doses over the volumes of organs/tissues. Figures 4 and 5 show typical values of specific AFs of energy in the volumes of various organs of a rat when they were irradiated to electrons with different energies. Example of ‘Specific self-absorbed fraction’ values in various organs of experimental rat vs energy of electrons, MeV. The term ‘Specific self-absorbed fraction’, g−1, means AF per ‘target’ organ’s mass for a case when ‘source’ organ and ‘target’ organ are the same. Example of specific absorbed fractions (SAF) values, g−1, vs energy of electrons, MeV: rat’s liver (‘source’) irradiating stomach (‘target’). Table 1 shows the results of absorbed dose estimations in considered organs and tissues of experimental rats. Table 1 31Si activity concentrations (A0) and corresponding absorbed doses (D) in organs and tissues of Wistar ratsOrgansA0, kBq/g(±2 SD)D, mGy(±2 SD)Blood0.07 ± 0.020.19 ± 0.06Thymus0.32 ± 0.080.94 ± 0.3Trachea0.62 ± 0.21.9 ± 0.6Lungs3.5 ± 0.911 ± 4Heart0.071 ± 0.020.23 ± 0.08Liver0.067 ± 0,020.28 ± 0.1Spleen0.12 ± 0.040.46 ± 0.2Kidney0.035 ± 0.010.11 ± 0.04Esophagus0.81 ± 0.32.6 ± 0.9Stomach18 ± 624 ± 8Jejunum27 ± 736 ± 12Ileum1.1 ± 0.33.7 ± 2Large intestine67 ± 20120 ± 40Bladder0.15 ± 0.040.34 ± 0.1Testis0.059 ± 0.020.14 ± 0.05Skin9.9 ± 319 ± 6Thigh muscle0.15 ± 0.040.36 ± 0.1Eyes3.1 ± 0.810 ± 3Cerebrum0.14 ± 0.040.31 ± 0.1Cerebellum0.091 ± 0.030.21 ± 0.07 31Si activity concentrations (A0) and corresponding absorbed doses (D) in organs and tissues of Wistar rats CONCLUSIONS AND DISCUSSION We estimated the values of internal radiation doses of various organs and tissues of experimental Wistar rats exposed to sprayed neutron-activated 31SiO2 microparticles. Doses of internal radiation could be conditionally divided into three groups according to their values. It was found that elevated dose values of internal irradiation of rats’ organs/tissues as a result of exposure to sprayed 31SiO2 microparticles with initial activity of 3.2 × 107 Bq ranged from 10 to 120 mGy (eyes, lungs, skin, stomach, jejunum, large intestine). Moderate dose values ranged from 1.9 to 3.7 mGy (trachea, esophagus, ileum). The smallest doses were received by the kidney, testis, blood, cerebellum, heart, liver, cerebrum, bladder, spleen and thymus (from 0.11 to 0.94 mGy). High and moderate levels of radiation doses to the gastrointestinal tract, esophagus, skin, eyes, lungs and trachea could be explained by the following: (i) swallowing of the radioactive particles by the rats due to the natural process of hair’s cleaning and grooming; (ii) a retention of sprayed microparticles on the hair and skin of the rats and (iii) inhalation of radioactive microparticles. It should be noted that the activity of sprayed neutron-activated 31SiO2 microparticles used in the study (3.2 × 107 Bq) was about nine times less than the activity of sprayed neutron-activated 56MnO2 microparticles used in experiments [21, 23]. Moreover, the mean energy of 31Si beta particles (0.595 MeV) was less than the mean energy of 56Mn beta particles (0,829 MeV). This is the reason why dose estimates related to internal irradiation of rats by sprayed neutron-activated 31SiO2 is significantly less in comparison with dose estimates in experiments with 56MnO2 microparticles [21, 23]. It is necessary to emphasize that the peculiarities of internal exposure to radioactive microparticles and the associated radiobiological effects of radiation exposure on animals are the focus of current studies [43–47]. The data obtained in our study are necessary for the interpretation of the results of ongoing and planned biological experiments with various activities of sprayed 31SiO2 microparticles—for comparative analysis regarding the features of biological effects caused by internal exposure to radioactive microparticles, having different types of radiation. It should be noted that the estimated values of internal radiation dose are the average doses over volumes of considered organs/tissues of experimental animals. The investigations of features of dose distribution on the level of biological microstructures irradiated by 31Si are ongoing now (similar to that, what was done for 56Mn [18, 29]). ACKNOWLEDGEMENTS The authors express their gratitude to the team of the Institute of Nuclear Physics, Almaty, Kazakhstan (‘Research Nuclear Reactor WWR-K’) for their cooperation and the opportunity to use the reactor and irradiate the materials under study. Contributor Information Valeriy Stepanenko, A. Tsyb Medical Radiological Research Center, Branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, 4 Koroleva St., Obninsk, Kaluga Region 249036, Russian Federation. Hitoshi Sato, Ibaraki Prefectural University of Health Sciences, 4669-2 Ami, Ami-machi, Inashiki-gun, Ibaraki 300-0394, Japan. Andrey Kaprin, National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, 4, Koroleva Str., Obninsk, Kaluga Region 249036, Russian Federation; Peoples’ Friendship University of Russia, 6 Miklukho-Maklaya St., Moscow 117198, Russian Federation; P.A. Hertzen Moscow Oncology Research Institute-Branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, 2nd Botkinsky Drive 3, Moscow 125284, Russian Federation. Nariaki Fujimoto, Research Institute for Radiation Biology and Medicine, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima 734-8551, Japan. Almagul Kushugulova, Nazarbayev University, 53 Kabanbay Batyr Avenue, Astana City 010000, Republic of Kazakhstan. Sergey Ivanov, A. Tsyb Medical Radiological Research Center, Branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, 4 Koroleva St., Obninsk, Kaluga Region 249036, Russian Federation; Peoples’ Friendship University of Russia, 6 Miklukho-Maklaya St., Moscow 117198, Russian Federation. Peter Shegay, National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, 4, Koroleva Str., Obninsk, Kaluga Region 249036, Russian Federation. Viktoria Bogacheva, A. Tsyb Medical Radiological Research Center, Branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, 4 Koroleva St., Obninsk, Kaluga Region 249036, Russian Federation. Alexey Petukhov, A. Tsyb Medical Radiological Research Center, Branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, 4 Koroleva St., Obninsk, Kaluga Region 249036, Russian Federation. Kassym Zhumadilov, International Department of Nuclear Physics, New Materials and Technology, L. N. Gumilyov Eurasian National University, 13 Munaitpasova St., Astana City 010008, Republic of Kazakhstan. Evgenia Ostroumova, Environment and Lifestyle Epidemiology Branch, International Agency for Research on Cancer/WHO, 25 Avenue Tony Garnier, Lyon 69366, France. Hiroshi Yasuda, Research Institute for Radiation Biology and Medicine, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima 734-8551, Japan. Noriyuki Kawano, The Center for Peace, Hiroshima University, Higashisenda-machi 1-1-89, Naka-ku, Hiroshima 730-0053, Japan. Megu Ohtaki, The Center for Peace, Hiroshima University, Higashisenda-machi 1-1-89, Naka-ku, Hiroshima 730-0053, Japan. Satoru Endo, Graduate School of Advanced Science and Engineering, Hiroshima University, 1-4-1, Kagamiyama, Higashi, Hiroshima 739-8527, Japan. Aya Sakaguchi, Institute of Pure and Applied Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8577, Japan. Laura Chulenbayeva, Nazarbayev University, 53 Kabanbay Batyr Avenue, Astana City 010000, Republic of Kazakhstan. Nurislam Mukhanbetzhanov, Nazarbayev University, 53 Kabanbay Batyr Avenue, Astana City 010000, Republic of Kazakhstan. Masaharu Hoshi, The Center for Peace, Hiroshima University, Higashisenda-machi 1-1-89, Naka-ku, Hiroshima 730-0053, Japan. AUTHOR CONTRIBUTIONS Conceptualization, M.H., V.S.; methodology, V.S., H.S., N.F., A.K.; validation, E.O., P.Sh.; formal analysis, A.Ka., S.I., N.K; investigation, V.S., H.S., A.K., V.B., K.Zh., A.S., L.Ch., N.M.; resources, M.H., A.K., A.Ka., S.I., P.Sh.; data curation, H.S., M.Oh., S.E., H.Ya.; writing—original draft preparation, V.S., M.H.; writing—review and editing, E.O., S.E., H.Ya; supervision, M.H., A.Ka., S.I., P.Sh.; project administration, M.H., A.Ka., A.K.; funding acquisition, M.H.. All authors have read and agreed to the published version of the manuscript. CONFLICT OF INTEREST The authors declare no conflict of interest. FUNDING This research was supported by Japan Society for the Promotion of Science KAKENHI (grants numbers: JP26257501, JP19H01149, JP19K09482, JP23K08570, JP19KK0266), and also by Environmental Radioactivity Research Network Center (grants F22–14 and F23–14); by Grant of Ministry of Science and Higher Education of the Republic of Kazakhstan for scientific and scientifical and technical projects AP19678341, Agreement No 269/23–25 of 3 August 2023; by grant from the Ministry of Science and Higher Education of the Republic of Kazakhstan AP23484543; the research was supported also by personnel of A. Tsyb Medical Radiological Research Center—Branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation in a framework of bilateral International Agreements on scientific cooperation with Hiroshima University (Japan), and L.N. Gumilyov Eurasian National University (Republic of Kazakhstan). DATA AVAILABILITY All authors are ready to provide data upon request. ETHICAL APPROVAL Ethical approval of animal experiment was received from the Ethics Committee of Kazakh National Medical University named after S.D. Asfendiyarov (Protocol # 7 (145), September 7, 2023, Almaty, Republic of Kazakhstan). DISCLAIMER Where authors are identified as personnel of the International Agency for Research on Cancer/World Health Organization, the authors alone are responsible for the views expressed in this article and they do not necessarily represent the decisions, policy or views of the International Agency for Research on Cancer/World Health Organization. REFERENCES Associated Data Data Availability Statement All authors are ready to provide data upon request.